What You Should Know: - AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, recently announced its Series F Financing led by GE Healthcare. - The round also included participation from Pegasus Tech Ventures) and existing investors including Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, and WP Global Partners. Providing End-to-End Cardiological Care Using Subscription Services AliveCor, Inc. is transforming cardiological care using deep
Read More
Analysis: How Will The Roadmap for Diagnostic Cardiology Devices Develop?
Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 pandemic saw global revenues for Resting ECG devices increase in 2020, whilst ECG Management Systems, Stress ECG and Traditional Holter ECG solutions saw a market decline. Country lockdowns resulted in reduced cardiology services during the peak of the pandemic, as non-urgent appointments were delayed. 2021 showed relief for cardiac facilities as providers started to deal with the
Read More
ITC Judge Finds Apple Infringed AliveCor Patents
What You Should Know: - Today, an International Trade Commission (ITC) judge issued an Initial Determination that Apple infringed AliveCor’s valid patented technology – a finding that may result in a limited exclusion order that will prohibit the import of infringing Apple Watches into the United States. - AliveCor initially filed its complaint with the ITC in April 2021, alleging that Apple infringed AliveCor’s
Read More
Solve.Care Launches First Crypto Healthcare Device Marketplace
What You Should Know: - Solve.Care, the global healthcare blockchain technology company, has announced the world's first crypto-enabled marketplace dedicated to healthcare. - Care.Marketplace will allow for the purchase of domestic healthcare devices across the United States. This first-of-its-kind development will work to influence the use of domestic healthcare devices Crypto-Enabled Marketplace Solve.Care is creating innovative solutions to long-standing access challenges within
Read More
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
GE Healthcare & AliveCor Integrate Data from ECGs Into Clinical Workflow
What You Should Know: - AliveCor and GE Healthcare announced they are partnering to integrate data from AliveCor’s KardiaMobile 6L electrocardiogram (ECG) device directly into GE Healthcare’s MUSE Cardiac Management System (MUSE). - Today, cardiologists often rely on real-time data from personal electrocardiogram (ECG) devices to help manage patients with cardiac conditions like atrial fibrillation (AFib). AliveCor’s KardiaMobile 6L ECG offers the only
Read More
AliveCor Launches KardiaMobile Card, World’s First Credit-Card-Sized Personal ECG
What You Should Know: - Today, AliveCor is launching KardiaMobile Card, the latest generation of personal electrocardiogram (ECG) technology that, at the size of the credit card, is the thinnest, lightest ECG device ever created and fits in any wallet. - The FDA-cleared KardiaMobile Card detects six of the most common heart arrhythmias in 30 seconds – something no other personal ECG can do – making it the most important card in your wallet. KardiaMobile Card: Instant Feedback on Heart
Read More
AliveCor, AstraZeneca Partner to Screen for Blood Potassium Levels Via Electrocardiograms
What You Should Know: - AliveCor, a digital AI-based personal technology provider, and AstraZeneca, a global leader in the biopharmaceutical space, are working together to create more informed disease management solutions across cardiovascular, renal, and metabolism therapeutic areas. - The collaboration will focus on the development of AliveCor’s potassium detection technology through their Kardia-K AI platform, to screen for elevated levels of blood potassium via electrocardiograms.
Read More
AliveCor Receives FDA Clearance of Next-Gen EKG Algorithms
What You Should Know: - AliveCor announced they received FDA clearance of new
algorithms for use with their personal EKG devices, KardiaMobile and
KardiaMobile 6L. These additional determinations will be available via a
software upgrade for the Kardia devices in 2021. - The additional FDA-cleared algorithms double the number
of heart rhythm disturbances that AliveCor’s Kardia devices can detect,
broadening the number of patients who are able to use their remote
Read More
AliveCor Receives “Breakthrough Device” Designation from FDA for Bloodless Hyperkalemia Test
AliveCor, a Mountain View, CA-based digital health startup developing solutions to transform cardiac care, announced on Monday received “breakthrough device” designation from the U.S. Food and Drug Administration for their bloodless hyperkalemia test. Developed with Mayo Clinic, AliveCor’s KardiaK Platform screens for elevated levels of blood potassium – hyperkalemia, without requiring any blood from the patient.This designation signals that the FDA will consider the technology on an
Read More
